Television advertising of pharmacy medicines in the United Kingdom

被引:1
|
作者
John, DN [1 ]
Evans, SW [1 ]
机构
[1] Cardiff Univ, Welsh Sch Pharm, Cardiff CF10 3XF, S Glam, Wales
来源
PHARMACY WORLD & SCIENCE | 2000年 / 22卷 / 04期
关键词
advertising; community pharmacy; non-prescription medicines;
D O I
10.1023/A:1008774031232
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the UK pharmacy is often promoted as the first port of call for minor ailments and the pharmacist's armamentarium of products is increasing as further products are reclassified from prescription only control. Non-prescription medicines in the UK can be advertised directly to the public but the advertisements must comply with the law. Some medicines, namely pharmacy can only be sold from pharmacies by, or under, the supervision of a pharmacist. This report describes the major findings of a postal survey of community pharmacists on the subject of advertising of pharmacy medicines and put them into context by outlining the legal and quasi-legal requirements. Further other studies concerning the advertising of non-prescription medicines are discussed in the context of requests for, and sales of, medicines available without a prescription.
引用
收藏
页码:136 / 139
页数:4
相关论文
共 50 条
  • [31] Differences in pharmacy terminology and practice between the United Kingdom and the United States
    Brock, Tina Penick
    Franklin, Bryony Dean
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (14) : 1541 - 1546
  • [32] United Kingdom GPs and pharmacists condemn Internet medicines
    不详
    [J]. EJHP PRACTICE, 2009, 15 (03): : 15 - 15
  • [33] Trends in licence approvals for ophthalmic medicines in the United Kingdom
    Peter J. Morgan-Warren
    Jiten B. Morarji
    [J]. Eye, 2020, 34 : 1856 - 1865
  • [34] LICENSING AND PROVISION OF MEDICINES IN THE UNITED-KINGDOM - AN APPRAISAL
    COLLIER, J
    [J]. LANCET, 1985, 2 (8451): : 377 - 381
  • [35] A REGULATORY VIEW OF THE MEDICINES ACT IN THE UNITED-KINGDOM
    ANDREWS, PA
    THOMPSON, GM
    WARD, C
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 24 (01): : 6 - 18
  • [36] Rethinking transparency and accountability in medicines regulation in the United Kingdom
    Abraham, J
    Sheppard, J
    Reed, T
    [J]. BRITISH MEDICAL JOURNAL, 1999, 318 (7175): : 46 - 47
  • [37] Trends in licence approvals for ophthalmic medicines in the United Kingdom
    Morgan-Warren, Peter J.
    Morarji, Jiten B.
    [J]. EYE, 2020, 34 (10) : 1856 - 1865
  • [38] Access divergence to new cancer medicines in the United Kingdom
    Lythgoe, Mark P.
    Blagden, Sarah
    Stanway, Susannah
    Sullivan, Richard
    [J]. EUROPEAN JOURNAL OF CANCER, 2024, 207
  • [39] WOMEN IN PHARMACY - A VIEW FROM THE UNITED-KINGDOM
    MORLEY, A
    PANTON, R
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1988, 13 (05) : 317 - 320
  • [40] The organisation and development of primary care pharmacy in the United Kingdom
    Silcock, J
    Raynor, DKT
    Petty, D
    [J]. HEALTH POLICY, 2004, 67 (02) : 207 - 214